EP1441702

NEURIM PHARMACEUTICALS
Application Number
EP02760523A
Filing Date
Aug 12, 2002
Status
Revoked
Jan 29, 2021
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP1441702B1 was granted to Neurim Pharmaceuticals on May 10, 2017 following the initial filing on Aug 12, 2002 under the application number EP02760523A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ORIFARM GENERICSApr 8, 2020INTERVENTION ADMISSIBLE
TEVA PHARMACEUTICALSFeb 12, 2018WITHDRAWN
ASPIRE PHARMAFeb 9, 2018ADMISSIBLE
GENERICS UKFeb 9, 2018ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents